E-LIB Suche - Ergebnisse für: Meraviglia, P

1

PIN159 Factors Associated with Health-Related Quality of Li..:

Foglia, E. ; Menzaghi, B. ; Rizzardini, G....
Value in Health. 23 (2020) - p. S570 , 2020

Link: https://doi.org/10.1016/..

2

Dolutegravir (DTG)-containing regimens after receiving ralt..:

Rusconi, S. ; Adorni, F. ; Tau, P....
Journal of Clinical Virology. 105 (2018) - p. 112-117 , 2018

Link: https://doi.org/10.1016/..

3

Clinical and genetic factors associated with kidney tubular..:

Salvaggio, S. E. ; Giacomelli, A. ; Falvella, F. S....
BMC Infectious Diseases. 17 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

4

Cost Analysis Of Comorbities: Evidence From A Hiv+ Patients..:

Foglia, E ; Ferrario, L ; Garagiola, E...
Value in Health. 19 (2016) 7 - p. A410-A411 , 2016

Link: https://doi.org/10.1016/..

5

Tenofovir plasma concentrations in post-menopausal versus p..:

Gervasoni, C. ; Meraviglia, P. ; Landonio, S....
Journal of Antimicrobial Chemotherapy. 68 (2013) 5 - p. 1206-1207 , 2013

Link: https://doi.org/10.1093/..

6

High burden of transmitted HIV-1 drug resistance in Italian..:

Franzetti, M. ; Lai, A. ; Roberto Simonetti, F....
Journal of Antimicrobial Chemotherapy. 67 (2012) 5 - p. 1250-1253 , 2012

Link: https://doi.org/10.1093/..

7

Incidence and risk factors of major cardiovascular events i..:

Carenzi, L ; Meraviglia, P ; Menzaghi, B...
Journal of the International AIDS Society. 15 (2012) S4 - p. 1-1 , 2012

Link: https://doi.org/10.7448/..

8

Inter- and intra-patient variability of raltegravir pharmac..:

Cattaneo, D. ; Gervasoni, C. ; Meraviglia, P....
Journal of Antimicrobial Chemotherapy. 67 (2011) 2 - p. 460-464 , 2011

Link: https://doi.org/10.1093/..

9

Maraviroc intensification for HIV-1-positive immunological ..:

Rusconi, S ; Vitiello, P ; Adorni, F...
Journal of the International AIDS Society. 13 (2010) - p. O44-O44 , 2010

Link: https://doi.org/10.1186/..

10

Long‐term follow‐up of HIV‐infected patients in salvage the..:

Landonio, S ; Meraviglia, P ; Capetti, AF...
Journal of the International AIDS Society. 13 (2010) S4 - p. , 2010

Link: https://doi.org/10.1186/..

11

Prevalence of transmitted HIV-1 drug resistance in HIV-1-in..:

Bracciale, L. ; Colafigli, M. ; Zazzi, M....
Journal of Antimicrobial Chemotherapy. 64 (2009) 3 - p. 607-615 , 2009

Link: https://doi.org/10.1093/..

12

Raltegravir therapy in HIV multi-experience patients: safet..:

Meraviglia, P ; Capetti, A ; Merli, S...
Journal of the International AIDS Society. 11 (2008) Suppl 1 - p. P31 , 2008

Link: https://doi.org/10.1186/..

13

Antiretroviral treatment and age‐related comorbidities in a..:

Orlando, G ; Meraviglia, P ; Cordier, L...
HIV Medicine. 7 (2006) 8 - p. 549-557 , 2006

Link: https://doi.org/10.1111/..

14

Lopinavir/ritonavir treatment in HIV antiretroviral‐experie..:

Meraviglia, P ; Schiavini, M ; Castagna, A...
HIV Medicine. 5 (2004) 5 - p. 334-343 , 2004

Link: https://doi.org/10.1111/..

15

Management of diabetes mellitus in people living with HIV: ..:

Cattaneo D ; Gidaro A ; Rossi A...
info:eu-repo/semantics/altIdentifier/pmid/36712651. , 2023

Link: https://hdl.handle.net/2..